You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune Checkpoint Inhibitors

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myocarditis, Immune Checkpoint Inhibitors, Cardiotoxicity Trial in Adelaide (Immune Checkpoint Inhibitors)

Recruiting
  • Myocarditis
  • +3 more
  • Immune Checkpoint Inhibitors
  • Adelaide, South Australia, Australia
    Flinders Medical Centre
Apr 21, 2022

Hepatocellular Carcinoma Trial in Shanghai (Anlotinib and TQB2450)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Anlotinib and TQB2450
  • Shanghai, Shanghai, China
    Zhongshan hospital
Sep 4, 2023

Endocrine Autoimmune Toxicity Due to Immune Checkpoint

Recruiting
  • Thyroid
  • +2 more
    • New York, New York
      Mount Sinai Hospital /Tisch Cancer Cancer/Ruttenberg Treatment C
    Oct 25, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Candiolo (inulin, Pembrolizumab, Nivolumab)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • inulin
    • +2 more
    • Candiolo, Turin, Italy
      Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
    Apr 7, 2023

    Thymic Carcinoma Trial in New York (KN046)

    Recruiting
    • Thymic Carcinoma
    • New York, New York
      Weill Cornell Medicine
    Sep 20, 2022

    Pre-transplant ICI Exposure and Post-transplant Graft Rejection

    Recruiting
    • Graft Rejection
    • +3 more
    • Immune checkpoint inhibitor
    • Guangzhou, Guangdong, China
      Organ Transplantation Center, Sun Yat-sen Memorial Hospital, Sun
    Jun 21, 2023

    CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors

    Recruiting
    • Myocarditis
    • +5 more
    • Paris, France
      AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
    Aug 19, 2022

    Cancer, Immune-related Adverse Event, Cardiac Abnormalities, Variable Trial in Belgium (Cardiology consultation, Chest Computed

    Recruiting
    • Cancer
    • +6 more
    • Cardiology consultation
    • +4 more
    • Deinze, East-Flanders, Belgium
    • +3 more
    Jan 26, 2023

    Quality of Life and Physical Fitness After Immune Checkpoint

    Completed
    • Melanoma
    • Non Small Cell Lung Cancer
      • Groningen, Netherlands
        University Medical Center Groningen
      Jan 3, 2023

      Acute Radiation Pneumonitis in Prior Receipt of Immune

      Recruiting
      • Cancer Patients
      • Cancer patients underwent thoracic intensity-modulated radiotherapy
      • Wuhan, Hubei, China
        Hubei Cancer Hospital
      Aug 4, 2022

      Metastatic Lung Cancer Trial in Beer sheva, Petah Tikva (Antibiotics, FMT (Fecal Microbiota Transplantation), Placebo

      Not yet recruiting
      • Metastatic Lung Cancer
      • Beer sheva, Israel
      • +1 more
      Aug 14, 2022

      Checkpoint Inhibitors in Triple Negative Breast

      Recruiting
      • Triple Negative Breast Cancer
      • Whole Genome Sequencing
      • +7 more
      • Barcelona, Spain
        Vall d'Hebron Institute of Oncology
      Jun 20, 2023

      Relapsed/Refractory Non-Hodgkin Lymphoma, Advanced Solid Tumors Trial in Beijing (Chidamide, Decitabine, Immune checkpoint

      Recruiting
      • Relapsed/Refractory Non-Hodgkin Lymphoma
      • Advanced Solid Tumors
      • Beijing, Beijing, China
        Biotherapeutic Department, Chinese PLA General Hospital
      Apr 8, 2022

      Renal Cell Carcinoma Trial in Rome (donor FMT, Placebo FMT)

      Recruiting
      • Renal Cell Carcinoma
      • donor FMT
      • Placebo FMT
      • Rome, Italy
      • +1 more
      Jul 26, 2022

      NSCLC, Metastatic Lung Non-Small Cell Carcinoma, Non Small Cell Lung Cancer Trial (Palliative Radiotherapy: 5 x 4Gy, chemo +

      Not yet recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +2 more
      • Palliative Radiotherapy: 5 x 4Gy
      • chemotherapy + immune checkpoint inhibitors
      • (no location specified)
      Jun 27, 2022

      Lung Cancer, Chronic Stress Disorder, Immune Checkpoint Inhibitors Trial in Changsha (Gut microbiota detection, Peripheral

      Recruiting
      • Lung Cancer
      • +2 more
      • Gut microbiota detection
      • Peripheral immune cells signature detaction
      • Changsha, Hunan, China
        Department of Oncology, The Second Xiangya Hospital, Central Sou
      Jul 26, 2022

      Neurological Immune-related Adverse Events

      Recruiting
      • Neurological Disease
      • Analysis of biomarkers and their correlation with clinical characteristics and outcome
      • Bron, France
        Centre de référence des syndromes neurologiques paranéoplasiques
      Jul 28, 2023

      Esophageal Carcinoma Trial (Immune Checkpoint Inhibitors)

      Not yet recruiting
      • Esophageal Carcinoma
      • Immune Checkpoint Inhibitors
      • (no location specified)
      Jul 6, 2023

      Lung Cancer Trial in Shanghai (chemo plus TCM 1&ICIs plusTCM2 , chemo plus TCM 1 &ICIs plus TCM2 )

      Not yet recruiting
      • Lung Cancer
      • chemotherapy plus TCM 1&ICIs plusTCM2 placebo
      • chemotherapy plus TCM 1placebo &ICIs plus TCM2 placebo
      • Shanghai, Shanghai, China
        YueYang Hosptial of Intergrated Traditional Chinese and Western
      Apr 17, 2023

      Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

      Active, not recruiting
      • Tumor Skin
      • +2 more
      • OBX-115
      • Orlando, Florida
      • +1 more
      Sep 28, 2023

      NSCLC Stage IV Trial in Hangzhou (SBRT)

      Recruiting
      • NSCLC Stage IV
      • SBRT
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      May 22, 2022

      Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

      Recruiting
      • Hepatocellular Carcinoma
      • Hong Kong, Hong Kong
        Department of Clinical Oncology, Queen Mary Hospital
      Apr 10, 2023

      Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

      Recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • Core needle biopsy
      • Madison, Wisconsin
        Elephas
      Aug 4, 2022

      NSCLC Trial in Rotterdam (Nutritional intervention, Immunotherapy)

      Recruiting
      • Non-small Cell Lung Cancer
      • Rotterdam, Netherlands
        Erasmus MC
      Jun 5, 2023

      Immune Checkpoint Inhibitors Nephrotoxicity

      Recruiting
      • Kidney Injury
      • Antineoplastics Toxicity
      • Early kidney damage biomarkers
      • Predisposition to kidney injury biomarkers
      • Salamanca, Spain
      • +1 more
      Jul 26, 2022